| Layer-by-layer fabrication of three dimensional (3D)
objects from digital models is called 3D printing.
This technology established just about three decades
ago at the confluence of materials science, chemistry,
robotics, and optics researches to ease the fabrication
of UV-cured resin prototypes. The 3D technology
was rapidly considered as a standard instrument
in the aerospace, automotive, and consumer
goods production factories. Nowadays, research
interests in the 3D printed products have been
raised and achieved ever-increasing traction in the
pharmaceutical industry; so that, the first 3D printed
drug product was approved by FDA in August
2015. This editorial summarizes the competitive
advantages of the 3D printing for the made-ondemand,
personalized and complex products,
manufacturing of which establish opportunities for
enhancing the accessibility, effectiveness, and safety
of drugs. |